Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

a person with no recent major clinical risk factor for VTE (see provoked DVT or PE) who is not having hormonal therapy (combined oral contraceptive pill or hormone replacement therapy). Wells score Clinical prediction rule for estimating the probability of DVT or PE. There are a number of versions of Wells scores available. This guideline recommends the 2-level DVT Wells score and the 2-level PE Wells score. Recommendations for research The guideline committee has made the following recommendations for research. Key recommendations for research 1 Clinical and cost effectiveness of inferior vena caval filters in people with venous thromboembolism What is the short- and long-term clinical and cost effectiveness of inferior vena caval filters in people with venous thromboembolism (VTE)? [2020] For a short explanation of why the committee made the recommendation for research, see the rationale section on inferior vena caval filters. Full details of the evidence and the committee's discussion are in evidence review H: inferior vena caval filters for people with VTE. 2 Clinical and cost effectiveness of direct-acting oral anticoagulants based on individual patient data What is the clinical and cost effectiveness of direct-acting oral anticoagulants (DOACs) compared with each other, with low molecular weight heparin
